Article Text

Download PDFPDF

The TRAF6 binding molecule p62/SQSTM1 is a critical regulator of inflammatory bone destruction
  1. A Korb1,
  2. A Hillmann1,
  3. S Bürgis2,
  4. G Kollias3,
  5. S Hermann4,
  6. M Schäfers4,
  7. T Pap5,
  8. T Weide1,
  9. A Gessner2,
  10. H Pavenstädt1
  1. 1Department Nephrology and Rheumatology, University Hospital Muenster, Germany
  2. 2Department Immunology, University Erlangen, Germany
  3. 3BSRC Fleming, Vari, Greece
  4. 4European Institute of Molecular Imaging, University Muenster, Germany
  5. 5Div Mol Med Musculoskeletal Tissue, University Hospital Muenster, Germany

Statistics from

The activation of nuclear factor κB (NFκB) via RANK is essential in regulating osteoclastogenesis. Under inflammatory conditions this process is enhanced by cytokines such as tumour necrosis factor α (TNFα). P62/SQSTM1 directly modulates these pathways through complex formation with TRAF6, aPKCs and ubiquitin. However, the role of p62/SQSTM1 in regulating bone turnover under inflammatory conditions, and specifically the role of the signal transduction domains of p62/SQSTM1, is unclear.

Mice were generated that carry a shortened but functional mutant of p62 with defective signal transduction domains (p62aaΔ69-251) for interbreeding studies with arthritic human TNF transgenic (hTNFtg) mice. The resulting genotypes (wild-type (wt), hTNFtg, p62aaΔ69-251 and hTNFtg/p62aaΔ69-251/wt) were scored for clinical parameters (paw swelling, grip strength, weight) for 14 weeks. To quantify the extent of inflammation, cartilage degradation and number of osteoclasts, joints of 14-week-old mice were embedded into paraffin and stained with toluidine-blue and tartrate-resistant acid phosphatase. To identify abnormalities in bone metabolism and bone structure, high resolution micro-CT scanning and positron emission tomography using 18-deoxyfluoroglucose fluoride (FDG-PET) were performed in 14-week-old mice of all genotypes in vivo. In addition, bone marrow derived monocytes (BMDMs) were isolated from all genotypes and osteoclastogenesis was studied using an established osteoclast formation assay. To investigate the underlying signalling pathways, cells were treated with TNFα at different time points and the activation of mitogen-activated protein kinases was studied by western blot analysis.

Histology and in vivo PET/CT studies revealed increased bone metabolism and bone mass in the hind paws, knees and vertebrae of p62aaΔ69-251 mice, but only minor changes were seen in the number and size of osteoclasts between p62aaΔ69-251 and wt animals suggesting that, under physiological conditions, regulatory mechanisms compensate for the lack of the signal transduction domains of p62. Compared with wt cells, however, BMDMs of p62aaΔ69-251 mice showed a significantly increased osteoclastogenesis, in particular when stimulated with TNFα. Crossing of p62aaΔ69-251 mice with hTNFtg animals resulted in a dramatic increase in the severity of joint damage in the hTNFtg/p62aaΔ69-251/wt mice, as determined clinically by histomorphometry and PET/CT analysis. This was accompanied by an increase in the number and size of osteoclasts in vivo. Western blot analysis of osteoclast lysates revealed increased TNFα-induced extracellular signal-regulated kinase phosphorylation in cells from p62aaΔ69-251 compared with wt mice.

Our data suggest that p62 is an important regulator of TNFα-mediated joint damage. They indicate that the loss of the TRAF6 and aPKCs binding domains has important consequences for osteoclastogenesis under inflammatory conditions.

View Abstract

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.